Healthcare - Biotechnology - NASDAQ - US
$ 3.47
-12.2 %
$ 247 M
Market Cap
-1.31
P/E
BALANCE SHEET
552 M
ASSETS
114 M
LIABILITIES
437 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Zentalis Pharmaceuticals, Inc.
| Current Assets | 497 M |
| Cash & Short-Term Investments | 483 M |
| Receivables | 0 |
| Other Current Assets | 13.8 M |
| Non-Current Assets | 55 M |
| Long-Term Investments | 0 |
| PP&E | 41.7 M |
| Other Non-Current Assets | 13.2 M |
| Current Liabilities | 69.4 M |
| Accounts Payable | 14.9 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 54.4 M |
| Non-Current Liabilities | 44.9 M |
| Long-Term Debt | 86.3 M |
| Other Non-Current Liabilities | -41.4 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 28.0 | 43.1 | 59.7 | 55.0 | 82.4 | 25.2 |
| Short Term Investments | 454.9 | 394.3 | 280.2 | 283.6 | 0 | 0 |
| Receivables | 0 | 0 | 2.6 | 0.4 | 0.1 | 0.9 |
| Inventory | 0 | (7.0) | (4.4) | 0 | 0 | 0 |
| Other Current Assets | 13.8 | 29.1 | 8.0 | 11.2 | 1.5 | 0.6 |
| Total Current Assets | 496.7 | 451.9 | 350.8 | 345.1 | 84.1 | 26.7 |
| PP&E | 41.7 | 50.1 | 52.8 | 3.6 | 2.8 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 8.8 | 8.8 | 8.8 |
| Goodwill | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 | 3.7 |
| Long Term Investments | 0 | 21.2 | 37.5 | 1.3 | 0.2 | 46.3 K |
| Other Long Term Assets | 9.5 | (1.8) | 2.6 | 2.3 | 2.2 | 1.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 551.7 | 539.3 | 454.5 | 365.6 | 102.7 | 41.0 |
| LIABILITIES | ||||||
| Accounts Payable | 14.9 | 11.2 | 11.6 | 8.7 | 4.3 | 3.4 |
| Short Term Debt | 0 | 0 | 1.5 | 0.9 | 0.8 | 0 |
| Other Current Liabilities | 54.2 | 45.4 | 29.9 | 18.6 | 9.8 | 2.8 |
| Total Current Liabilities | 69.4 | 56.6 | 43.9 | 28.6 | 14.9 | 6.2 |
| Long Term Debt | 86.3 | 90.3 | 88.9 | 1.1 | 0 | 0 |
| Deferred Tax Income | 0 | 0.9 | 1.6 | 2.5 | 2.5 | 2.5 |
| Other Liabilities | (41.4) | (42.5) | (44.5) | 0 | 0.9 | 21 K |
| Total Liabilities | 114.3 | 105.3 | 90.0 | 32.2 | 19.1 | 8.7 |
| EQUITY | ||||||
| Common Stock | 70 K | 59 K | 45 K | 41 K | 25 K | 2.3 |
| Retained Earnings | (888.6) | (596.4) | (359.6) | (200.8) | (83.0) | (37.3) |
| Other Accumulative Comprehensive Income/Loss | 2.2 | (1.4) | (0.1) | 36 K | (141.7) | 56 K |
| Total Equity | 437.4 | 434.2 | 365.0 | 358.2 | 83.6 | 32.3 |
| Total Liabilities and Equity | 551.7 | 539.3 | 454.5 | 365.6 | 102.7 | 41.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 65.4 | 52.9 | 42.7 | 41.0 | 35.9 | 18.1 |